We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. More than one-quarter of patients with COVID-19 had ...
It is difficult to predict risk for recurrent venous thromboembolism (VTE) precisely and, therefore, to assess whether prolonged anticoagulation therapy is appropriate. Austrian researchers ...
Feasibility of a prospective host cell reactivation assay (HCRA) in non-small cell lung cancer (NSCLC) patients. Background: Procoagulant changes in the haemostatic system and activation of ...
Des Plaines, IL — A new study investigating D-dimer testing in patients who are at higher risk of pulmonary embolism (PE) has been published in the February issue of Academic Emergency Medicine (AEM), ...
Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...
Close-up of a mother kissing her son A NYC hospital study explored disease severity in Black individuals with COVID-19 pneumonia, using D-dimer as a surrogate marker. Elevated D-dimer was ...
Please provide your email address to receive an email when new articles are posted on . Published results showed plasma D-dimer was noninferior to serum C-reactive protein and erythrocyte ...
Fibrin degradation products (FDPs) — also called fibrin split products — are small pieces of protein that stay in your blood when a blood clot dissolves inside your body. Doctors can test for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback